Subjects | Outcome | PCT | hsCRP | ||
---|---|---|---|---|---|
HR (95% CI)a | P | HR (95% CI)a | P | ||
All subjects | All-cause mortality | 1.15 (1.04 to 1.26) | 0.006** | 1.08 (0.98 to 1.19) | 0.100 |
Cancer mortality | 1.23 (1.06 to 1.41) | 0.005** | 1.02 (0.89 to 1.16) | 0.788 | |
CVD mortality | 1.08 (0.89 to 1.30) | 0.425 | 1.24 (1.03 to 1.49) | 0.025* | |
Mortality from causes other than cancer and CVD | 1.15 (0.95 to 1.39) | 0.161 | 1.07 (0.89 to 1.28) | 0.483 | |
Men | All-cause mortality | 1.13 (1.00 to 1.27) | 0.047* | 1.09 (0.97 to 1.23) | 0.156 |
Cancer mortality | 1.29 (1.08 to 1.54) | 0.006** | 0.96 (0.80 to 1.14) | 0.632 | |
CVD mortality | 1.04 (0.83 to 1.30) | 0.741 | 1.30 (1.01 to 1.66) | 0.037* | |
Mortality from causes other than cancer and CVD | 1.07 (0.86 to 1.34) | 0.556 | 1.16 (0.92 to 1.47) | 0.220 | |
Women | All-cause mortality | 1.13 (0.97 to 1.32) | 0.106 | 1.07 (0.92 to 1.24) | 0.362 |
Cancer mortality | 1.09 (0.88 to 1.35) | 0.430 | 1.13 (0.92 to 1.38) | 0.261 | |
CVD mortality | 1.19 (0.87 to 1.62) | 0.286 | 1.13 (0.84 to 1.51) | 0.433 | |
Mortality from causes other than cancer and CVD | 1.21 (0.87 to 1.67) | 0.251 | 0.92 (0.68 to 1.23) | 0.568 |